Zum Inhalt springen
Home » Belite Bio to Present at the JonesHealthcare Seaside Summit

Belite Bio to Present at the JonesHealthcare Seaside Summit

Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that Dr. Nathan Mata, Chief Scientific Officer of Belite Bio, will participate in the JonesHealthcare Seaside Summit in Encinitas,…

Belite Bio to Present at the JonesHealthcare Seaside Summit